CA2 | Carbonic anhydrase II | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CAPN9 | Calpain 9 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
DCHS2 | Dachsous cadherin-related 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DUSP4 | Dual specificity phosphatase 4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
EPN3 | Epsin 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
EPS8L1 | EPS8-like 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FOXA2 | Forkhead box A2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GALNT6 | Polypeptide N-acetylgalactosaminyltransferase 6 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL17REL | Interleukin 17 receptor E-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
ISL1 | ISL LIM homeobox 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
LGALS9B | Lectin, galactoside-binding, soluble, 9B | Predicted intracellular proteins
| | | | | Tissue enhanced |
LGALS9C | Lectin, galactoside-binding, soluble, 9C | Predicted intracellular proteins
| | | | | Tissue enhanced |
MLPH | Melanophilin | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NPSR1 | Neuropeptide S receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
S100P | S100 calcium binding protein P | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SCGN | Secretagogin, EF-hand calcium binding protein | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SLX1A-SULT1A3 | SLX1A-SULT1A3 readthrough (NMD candidate) | Predicted intracellular proteins
| | | | | Tissue enhanced |
SMIM6 | Small integral membrane protein 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMC5 | Transmembrane channel-like 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
UPK1B | Uroplakin 1B | Predicted membrane proteins
| | | | | Tissue enhanced |
VILL | Villin-like | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
VSIG2 | V-set and immunoglobulin domain containing 2 | Predicted membrane proteins
| | | | | Tissue enhanced |